Difference between revisions of "LncRNAWiki:Breast-cancer"

From LncRNAWiki
Jump to: navigation, search
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !width="50"|Cancer !width="50"|Name !width="50"|Transcript ID !width="50"|Alias !width="50"|Description !wi...")
 
Line 1: Line 1:
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
|-
 
|-
−
!width="50"|Cancer
 
 
!width="50"|Name
 
!width="50"|Name
 
!width="50"|Transcript ID
 
!width="50"|Transcript ID
 
!width="50"|Alias
 
!width="50"|Alias
 
!width="50"|Description
 
!width="50"|Description
−
!width="50"|Other Disease
+
!width="50"|Disease
 
|-
 
|-
−
|breast-cancer
 
 
|''CDKN2B-AS1''
 
|''CDKN2B-AS1''
 
|[[NONHSAT130421]],[[lnc-C9orf53-2:1]]
 
|[[NONHSAT130421]],[[lnc-C9orf53-2:1]]
 
|"ANRIL, p15AS, ENSG00000240498"
 
|"ANRIL, p15AS, ENSG00000240498"
 
|CDKN2B antisense RNA 1
 
|CDKN2B antisense RNA 1
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''MALAT1''
 
|''MALAT1''
 
|[[ENST00000534336.1]]
 
|[[ENST00000534336.1]]
 
|"HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562
 
|"HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562
 
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
 
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''HOTAIR''
 
|''HOTAIR''
 
|[[NONHSAT028508]]
 
|[[NONHSAT028508]]
 
|Gm16258, "Hox antisense intergenic RNA", ENSG00000228630
 
|Gm16258, "Hox antisense intergenic RNA", ENSG00000228630
 
|Hox antisense intergenic RNA
 
|Hox antisense intergenic RNA
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''GAS5''
 
|''GAS5''
 
|[[NONHSAT007663]]
 
|[[NONHSAT007663]]
Line 36: Line 31:
 
|"autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus"
 
|"autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus"
 
|-
 
|-
−
|breast-cancer
 
 
|''H19''
 
|''H19''
 
|[[NONHSAT017465]]
 
|[[NONHSAT017465]]
Line 43: Line 37:
 
|"bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor"
 
|"bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor"
 
|-
 
|-
−
|breast-cancer
 
 
|''MEG3''
 
|''MEG3''
 
|[[NONHSAT039745]]
 
|[[NONHSAT039745]]
 
|Gtl2, ENSG00000214548
 
|Gtl2, ENSG00000214548
 
|maternally expressed 3 (non-protein coding)
 
|maternally expressed 3 (non-protein coding)
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''XIST''
 
|''XIST''
 
|[[NONHSAT137541]]
 
|[[NONHSAT137541]]
 
|ENSG00000229807
 
|ENSG00000229807
 
|X inactive-specific transcript
 
|X inactive-specific transcript
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC01089''
 
|''LINC01089''
 
|[[LINC01089]]
 
|[[LINC01089]]
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1089
 
|long intergenic non-protein coding RNA 1089
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''EGOT''
 
|''EGOT''
 
|[[NONHSAT087635]]
 
|[[NONHSAT087635]]
 
|EGO, "eosinophil granule ontogeny", NCRNA00190,"non-protein coding RNA 190", ENSG00000235947
 
|EGO, "eosinophil granule ontogeny", NCRNA00190,"non-protein coding RNA 190", ENSG00000235947
 
|Eosinophil granule ontogeny (EGO) RNA
 
|Eosinophil granule ontogeny (EGO) RNA
−
|"breast cancer,"
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''JADRR''
 
|''JADRR''
 
|[[JADRR]]
 
|[[JADRR]]
Line 78: Line 67:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''RASSF1-AS1''
 
|''RASSF1-AS1''
 
|[[RASSF1-AS1]]
 
|[[RASSF1-AS1]]
Line 85: Line 73:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''PANDAR''
 
|''PANDAR''
 
|[[lnc-CDKN1A-1:1]]
 
|[[lnc-CDKN1A-1:1]]
 
|"P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR"
 
|"P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR"
 
|promoter of CDKN1A antisense DNA damage activated RNA
 
|promoter of CDKN1A antisense DNA damage activated RNA
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''ZFAS1''
 
|''ZFAS1''
 
|[[NONHSAT080206]]
 
|[[NONHSAT080206]]
Line 99: Line 85:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''ARRDC1-AS1''
 
|''ARRDC1-AS1''
 
|[[ARRDC1-AS1]]
 
|[[ARRDC1-AS1]]
Line 106: Line 91:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''BCAR4''
 
|''BCAR4''
 
|[[BCAR4]]
 
|[[BCAR4]]
Line 113: Line 97:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''CASC22''
 
|''CASC22''
 
|[[CASC22]]
 
|[[CASC22]]
Line 120: Line 103:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''FAS-AS1''
 
|''FAS-AS1''
 
|[[FAS-AS1]]
 
|[[FAS-AS1]]
 
|SAF
 
|SAF
 
|FAS antisense RNA 1
 
|FAS antisense RNA 1
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC00160''
 
|''LINC00160''
 
|[[LINC00160]]
 
|[[LINC00160]]
Line 134: Line 115:
 
|Breast Cancer
 
|Breast Cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC00189''
 
|''LINC00189''
 
|[[LINC00189]]
 
|[[LINC00189]]
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 189
 
|long intergenic non-protein coding RNA 189
−
|Breast Cancer
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC00310''
 
|''LINC00310''
 
|[[LINC00310]]
 
|[[LINC00310]]
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 310
 
|long intergenic non-protein coding RNA 310
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC00323''
 
|''LINC00323''
 
|[[LINC00323]]
 
|[[LINC00323]]
 
|"PRED42, FLJ37173"
 
|"PRED42, FLJ37173"
 
|long intergenic non-protein coding RNA 323
 
|long intergenic non-protein coding RNA 323
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC00472''
 
|''LINC00472''
 
|[[LINC00472]]
 
|[[LINC00472]]
Line 162: Line 139:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC00704''
 
|''LINC00704''
 
|[[LINC00704]]
 
|[[LINC00704]]
Line 169: Line 145:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC00705''
 
|''LINC00705''
 
|[[LINC00705]]
 
|[[LINC00705]]
Line 176: Line 151:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC01016''
 
|''LINC01016''
 
|[[LINC01016]]
 
|[[LINC01016]]
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1016
 
|long intergenic non-protein coding RNA 1016
−
|Breast Cancer
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC01405''
 
|''LINC01405''
 
|[[LINC01405]]
 
|[[LINC01405]]
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1405
 
|long intergenic non-protein coding RNA 1405
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''NBR2''
 
|''NBR2''
 
|[[NBR2]]
 
|[[NBR2]]
Line 197: Line 169:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''NKILA''
 
|''NKILA''
 
|[[NKILA]]
 
|[[NKILA]]
 
|N/A
 
|N/A
 
|NF-kappaB interacting long non-coding RNA
 
|NF-kappaB interacting long non-coding RNA
−
| breast cancer
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''UMODL1-AS1''
 
|''UMODL1-AS1''
 
|[[UMODL1-AS1]]
 
|[[UMODL1-AS1]]
Line 211: Line 181:
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''ZNF667-AS1''
 
|''ZNF667-AS1''
 
|[[ZNF667-AS1]]
 
|[[ZNF667-AS1]]
 
|MORT
 
|MORT
 
|ZNF667 antisense RNA 1 (head to head)
 
|ZNF667 antisense RNA 1 (head to head)
−
|cancer
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''PVT1''
 
|''PVT1''
 
|[[ENST00000513868.2]]
 
|[[ENST00000513868.2]]
Line 225: Line 193:
 
|"breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer"
 
|"breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer"
 
|-
 
|-
−
|breast-cancer
 
 
|''BCYRN1''
 
|''BCYRN1''
 
|[[lnc-EPCAM-1:2]]
 
|[[lnc-EPCAM-1:2]]
Line 232: Line 199:
 
|"Alzheimer's disease,breast cancer,cervical cancer, lung cancer,oesophagus cancer, ovarian cancer, parotid cancer,tongue cancer"
 
|"Alzheimer's disease,breast cancer,cervical cancer, lung cancer,oesophagus cancer, ovarian cancer, parotid cancer,tongue cancer"
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC01024''
 
|''LINC01024''
 
|[[LINC01024]]
 
|[[LINC01024]]
 
|MA-linc1
 
|MA-linc1
 
|long intergenic non-protein coding RNA 1024
 
|long intergenic non-protein coding RNA 1024
−
|_
+
|breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''FOXCUT''
 
|''FOXCUT''
 
|[[Lnc-FOXC1-1:1]],[[NONHSAT106529]]
 
|[[Lnc-FOXC1-1:1]],[[NONHSAT106529]]
Line 246: Line 211:
 
|"esophageal squamous cell carcinoma, basal-like breast cancer"
 
|"esophageal squamous cell carcinoma, basal-like breast cancer"
 
|-
 
|-
−
|breast-cancer
 
 
|''NBAT1''
 
|''NBAT1''
 
|[[NBAT1]]
 
|[[NBAT1]]
 
|NBAT-1
 
|NBAT-1
 
|neuroblastoma associated transcript 1
 
|neuroblastoma associated transcript 1
−
|Fighting Neuroblastomas ;breast cancer
+
|Fighting Neuroblastomas,breast cancer
 
|-
 
|-
−
|breast-cancer
 
 
|''LSINCT5''
 
|''LSINCT5''
 
|[[LSINCT5]]
 
|[[LSINCT5]]
Line 260: Line 223:
 
|"gastric cancer,breast and ovarian cancer"
 
|"gastric cancer,breast and ovarian cancer"
 
|-
 
|-
−
|breast-cancer
 
 
|''LINC00993''
 
|''LINC00993''
 
|[[LINC00993]]
 
|[[LINC00993]]
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 993
 
|long intergenic non-protein coding RNA 993
−
|_
+
|breast cancer
 
|}
 
|}

Revision as of 08:00, 5 December 2016

Name Transcript ID Alias Description Disease
CDKN2B-AS1 NONHSAT130421,lnc-C9orf53-2:1 "ANRIL, p15AS, ENSG00000240498" CDKN2B antisense RNA 1 breast cancer
MALAT1 ENST00000534336.1 "HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562 metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) breast cancer
HOTAIR NONHSAT028508 Gm16258, "Hox antisense intergenic RNA", ENSG00000228630 Hox antisense intergenic RNA breast cancer
GAS5 NONHSAT007663 SNHG2, ENSG00000234741 _ "autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus"
H19 NONHSAT017465 Q96MK8,ENSG00000130600 "H19, imprinted maternally expressed transcript (non-protein coding)" "bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor"
MEG3 NONHSAT039745 Gtl2, ENSG00000214548 maternally expressed 3 (non-protein coding) breast cancer
XIST NONHSAT137541 ENSG00000229807 X inactive-specific transcript breast cancer
LINC01089 LINC01089 N/A long intergenic non-protein coding RNA 1089 breast cancer
EGOT NONHSAT087635 EGO, "eosinophil granule ontogeny", NCRNA00190,"non-protein coding RNA 190", ENSG00000235947 Eosinophil granule ontogeny (EGO) RNA breast cancer
JADRR JADRR lncRNA-JADE JADE1 adjacent regulatory RNA breast cancer
RASSF1-AS1 RASSF1-AS1 RASSF1 antisense RNA 1 ANRASSF1 breast cancer
PANDAR lnc-CDKN1A-1:1 "P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR" promoter of CDKN1A antisense DNA damage activated RNA breast cancer
ZFAS1 NONHSAT080206 Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410 ZNFX1 antisense RNA 1 breast cancer
ARRDC1-AS1 ARRDC1-AS1 N/A ARRDC1 antisense RNA 1 breast cancer
BCAR4 BCAR4 N/A breast cancer anti-estrogen resistance 4 (non-protein coding) breast cancer
CASC22 CASC22 "TCONSN/A00024290, LincRNA-ENST00000515084" cancer susceptibility candidate 22 (non-protein coding) breast cancer
FAS-AS1 FAS-AS1 SAF FAS antisense RNA 1 breast cancer
LINC00160 LINC00160 N/A long intergenic non-protein coding RNA 160 Breast Cancer
LINC00189 LINC00189 N/A long intergenic non-protein coding RNA 189 breast cancer
LINC00310 LINC00310 N/A long intergenic non-protein coding RNA 310 breast cancer
LINC00323 LINC00323 "PRED42, FLJ37173" long intergenic non-protein coding RNA 323 breast cancer
LINC00472 LINC00472 "dJ288M22.3, FLJ13189" long intergenic non-protein coding RNA 472 breast cancer
LINC00704 LINC00704 N/A long intergenic non-protein coding RNA 704 breast cancer
LINC00705 LINC00705 N/A long intergenic non-protein coding RNA 705 breast cancer
LINC01016 LINC01016 N/A long intergenic non-protein coding RNA 1016 breast cancer
LINC01405 LINC01405 N/A long intergenic non-protein coding RNA 1405 breast cancer
NBR2 NBR2 NCRNA00192 neighbor of BRCA1 gene 2 (non-protein coding) breast cancer
NKILA NKILA N/A NF-kappaB interacting long non-coding RNA breast cancer
UMODL1-AS1 UMODL1-AS1 FLJ33471 UMODL1 antisense RNA 1 breast cancer
ZNF667-AS1 ZNF667-AS1 MORT ZNF667 antisense RNA 1 (head to head) breast cancer
PVT1 ENST00000513868.2 "NCRNA00079, LINC00079, onco-lncRNA-100" Pvt1 oncogene (non-protein coding) "breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer"
BCYRN1 lnc-EPCAM-1:2 "BC200,BC200a, NCRNA00004, LINC00004" "BCYRN1, brain cytoplasmic RNA 1" "Alzheimer's disease,breast cancer,cervical cancer, lung cancer,oesophagus cancer, ovarian cancer, parotid cancer,tongue cancer"
LINC01024 LINC01024 MA-linc1 long intergenic non-protein coding RNA 1024 breast cancer
FOXCUT Lnc-FOXC1-1:1,NONHSAT106529 TCONS_00011636 FOXC1 upstream transcript (non-protein coding) "esophageal squamous cell carcinoma, basal-like breast cancer"
NBAT1 NBAT1 NBAT-1 neuroblastoma associated transcript 1 Fighting Neuroblastomas,breast cancer
LSINCT5 LSINCT5 N/A long stress-induced non-coding transcript 5 "gastric cancer,breast and ovarian cancer"
LINC00993 LINC00993 N/A long intergenic non-protein coding RNA 993 breast cancer
Retrieved from "https://ngdc.cncb.ac.cn/lncrnawiki1/index.php?title=LncRNAWiki:Breast-cancer&oldid=1272693"